Status:
COMPLETED
The Effect of Oral Azithromycin in the Treatment of Chlamydial Conjunctivitis
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Chlamydial Conjunctivitis
Eligibility:
All Genders
Phase:
NA
Brief Summary
Chlamydia trachomatis is one of the major causes of sexually transmitted disease and also the leading infectious cause of blindness in the world.Treatment of C. trachomatis eye infection has involved ...
Detailed Description
Medical records of patients with clinically suspected chlamydial conjunctivitis between January 1, 2006 and December 31, 2006 at one cornea specialist's (Y.C.H) out-patient clinic were retrospectively...
Eligibility Criteria
Inclusion
- Patients of clinically chlamydial conjunctivitis suspected and proven by direct fluorescent antibody(DFA)results
Exclusion
- Patients with pregnancy or lactation, history of allergy to macrolides, evidence or history of hepatic, renal, hematological or cardiovascular disease
Key Trial Info
Start Date :
September 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT01178762
Start Date
September 1 2007
End Date
December 1 2007
Last Update
October 27 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100